Position in RPRX
as of Mar 31, 2026
· filed Apr 17, 2026
Position Value
$527,670
-$6,566 QoQ
Shares Held
11,000
-20.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.53%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PSP Research LLC holds $27,398,755 across 69 Biotechnology names. RPRX ranks #6 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DFTX |
Definium Therapeutics, Inc.
|
34,800 | $657,720 | |
| 2 | TYRA |
Tyra Biosciences, Inc.
|
16,000 | $612,800 | |
| 3 | ASND |
Ascendis Pharma A/S
|
2,500 | $571,825 | |
| 4 | PHVS |
Pharvaris N.V.
|
20,000 | $565,000 | |
| 5 | CYTK |
Cytokinetics Inc
|
8,300 | $547,053 | |
| 6 | RPRX |
Royalty Pharma plc
This page
|
11,000 | $527,670 | |
| 7 | KYMR |
Kymera Therapeutics, Inc.
|
6,300 | $524,727 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
8,026 | $518,720 |
All Filings in RPRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $527,670 | 11,000 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $534,236 | 13,826 | Shares | Sole | 2026-02-06 | |
| No filing history on record for this holder in this stock. | ||||||